THE UTILIZATION OF DIOSGENIN FOR MANAGING THE GENETICALLY TRANSMITTED OPTIC NERVE SHEATH MENINGIOMAS (ONSMS). JRA [Internet]. 2024 Feb. 22 [cited 2025 Apr. 18];6(1). Available from: https://journlra.org/index.php/jra/article/view/1458